Growth medium effect on the antifungal activity of LY 303366

Diagnostic Microbiology and Infectious Disease

Volumn 29, Issue 4, 1997, Pages 227-231

  Klepser, Michael E ^a,c   Ernst, Erika J ^a   Ernst, Michael E ^a   Pfaller, Michael A ^a,b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; ECHINOCANDIN B DERIVATIVE; PROPANE; SULFONIC ACID DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA GLABRATA; CANDIDA TROPICALIS; CULTURE MEDIUM; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0031406366     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00144-2     Document Type: Article

References (9)

1. Chambers HF, Miller RT, Newman MD (1988) Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: Two-week combination therapy. Ann Intern Med 109:619-624.
2. Ernst ME, Klepser ME, Wolfe EJ, Pfaller MA (1996) Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida spp. Diagn Microbiol Infect Dis 26:125-131.
3. Friesen M, Harding G, Karlowsky J, Balko T, Hoban D, Zelenitsky S, Turik M, Zhanel GG (1996) Antifungal pharmacodynamic activity of the investigational echinocandin LY 303366 against fluconazole-sensitive and fluconazole-resistant Candida albicans. Abstract F49, p 108. Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, LA: American Society for Microbiology.
4. Klepser ME, Wolfe EJ, Pfaller MA (1996) Characterization of the fungicidal dynamics of fluconazole and amphotericin B against Cryptococcus neoformans via kill-curve methodologies. Abstract 77, p 50. Program and Abstracts of the 34th Annual Meeting. New Orleans, LA: Infectious Diseases Society of America.
5. Klepser ME, Wolfe EJ, Jones RN, Nightingale CH, Pfaller MA (1997) Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Candida albicans. Antimicrob Agents Chemother 41:1392-1395.
6. National Committee for Clinical Laboratory Standards (1997) Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard M27-A. Wayne, PA: NCCLS.
7. Pearson RD, Steigbigel RT, Davis HT, Chapman SW (1980) Method for reliable determination of minimum lethal antibiotic concentrations. Antimicrob Agents Chemother 18:699-708.
8. Pfaller MA, Rinaldi MG, Galgiani JN, Bartlett MS, Body BA, Espinel-Ingroff A, Fromtling RA, Hall GS, Hughes CE, Odds FC, Sugar FC (1990) Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob Agents Chemother 34:1648-1654.
9. Small PM and Chambers HF (1990) Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 34:1227-1231.